Jinan University
Also known as: Association for the Handicapped Of Jinan | Biological treatment center in Fuda cancer hospital Guangzhou, Guangdong, China, 510000 | Biomedical Translational Research Institute of Jinan University | Department of Cardiology, Jinan City People's Hospital | First Affiliated Hospital of Jinan University | Fuda Cancer Hospital | Fuda Cancer Hospital, Guangzhou | Gangzhou Red Cross Hospital ，Jinan University | Guangzhou FUDA Cancer Hospital | Jia-Nan Mental Hospital | Jinan Central Hospital | Jinan Children's Hospital | Jinan City Dermatology Hospital Prevention and Treatment | Jinan Hospital for Infectious Diseases | Jinan Mental Hospital | Jinan University | Jinan University, China | Jinan University Guangzhou | The Second Clinical Medical College of Jinan University | The Sixth Affliated Hospital of Jinan University | Yongpeng Wang
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2006Last known activity
Aug 31, 2025
Timeline
1900s
- Jun 1, 1906
Jinan University— Founded
Drugs by trial phase (106 distinct, 120 trials)
Phase 4 (14 own, 0 via acquisition)
Phase 3 (12 own, 0 via acquisition)
Phase 2 (57 own, 0 via acquisition)
Phase 1 (13 own, 0 via acquisition)
Other trials (10 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Alzheimer Disease
- Anemia
- Anemia, Aplastic
- Atrial Fibrillation
- Autistic Disorder
- Bipolar Disorder
- Brain Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Cerebral Infarction
- Cerebral Small Vessel Diseases
- Cognitive Dysfunction
- Colorectal Neoplasms
- Compulsive Personality Disorder
- Dementia
- Dermatitis
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Disease
- Erectile Dysfunction
- Esophageal Neoplasms
- Fibrosis
- Glioblastoma
- Glioma
- Heart Failure
- Heart Failure, Systolic
- Hepatitis
- Hepatitis B
- Hypersensitivity
- Infarction
- Inflammation
- Ischemia
- Ischemic Attack, Transient
- Kidney Neoplasms
- Laryngeal Neoplasms
- Leprosy
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Cirrhosis
- Liver Neoplasms
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Melanoma
- Menopause, Premature
- Myocardial Infarction
- Nasopharyngeal Carcinoma
- Nasopharyngeal Neoplasms
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Second Primary
- Obsessive-Compulsive Disorder
- Osteoarthritis
- Osteoarthritis, Knee
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Pharyngeal Neoplasms
- Pneumonia, Pneumocystis
- Premature Birth
- Primary Ovarian Insufficiency
- Prostatic Neoplasms
- Purpura, Thrombocytopenic, Idiopathic
- Sarcoma
- Skin Diseases
- Skin Diseases, Vesiculobullous
- ST Elevation Myocardial Infarction
- Stomach Neoplasms
- Stroke
- Thrombocytopenia
- Tongue Neoplasms
- Tuberculosis
- Tuberculosis, Multidrug-Resistant
- Urticaria
- Uterine Cervical Neoplasms
- Vasculitis
- Vasculitis, Leukocytoclastic, Cutaneous
Recent trials (50)
- NCT07116577OfficialPhase 2Aug 31, 2025
- NCT07116577Lead sponsorPhase 2Aug 31, 2025
- NCT07116577Sponsor investigatorPhase 2Aug 31, 2025
- NCT06983665OfficialN/AMay 25, 2025
- NCT06977490OfficialN/AMay 13, 2025
- NCT06701149OfficialPhase 1Nov 28, 2024
- NCT06614907OfficialPhase 1Aug 31, 2024
- NCT06526455CollaboratorPhase 4Aug 1, 2024
- NCT06412185OfficialPhase 1May 28, 2024
- NCT06732960CollaboratorPhase 2Apr 21, 2024
- NCT06118034CollaboratorPhase 3Jan 1, 2024
- NCT07169032Sponsor investigatorEarly Phase 1Jan 1, 2024
- NCT07169032Lead sponsorEarly Phase 1Jan 1, 2024
- NCT06822153OfficialPhase 1Nov 9, 2023
- NCT05913661CollaboratorPhase 2Jul 31, 2023
Details
- Founded
- Guangzhou, CN Jun 1, 1906
- Last known activity
- Aug 31, 2025